Mark Cuban isn’t afraid to admit when he doesn’t have the answers. When challenged about his wealth and its potential to solve world hunger, Cuban responded, “I’m dumb. I can’t figure out how to end world hunger.” But while he admits he doesn’t have all the answers, he’s making it clear that his focus is on fixing the broken healthcare system in the U.S.
It all started when a user on Bluesky, Cameron Polson, called out Cuban, saying, “This dude could LITERALLY end world hunger and would barely affect his net worth and he chooses not to.” Instead of ignoring the claim, Cuban responded, “I’m in! Tell me how.” Another user pushed back harder, saying, “If you can’t figure out how your money could help end hunger, then you aren’t quite as smart as you think you are.”
Don’t Miss:
Cuban, known for his sarcasm, shot back with, “I’m dumb. I can’t figure out how to end world hunger.” But he soon changed the topic to something he is now working on: lowering the cost of healthcare.
While Cuban might not have the solution for world hunger, he’s making waves in another critical area. He emphasized that he is fully committed to changing the way Americans access and afford medication, something he has been working on through his company, Cost Plus Drugs.
“I do promise that I will continue to change healthcare in this country and make it more affordable, possibly setting a path towards Universal Healthcare,” he said.
Trending: ‘Scrolling To UBI’ — Deloitte’s #1 fastest-growing software company allows users to earn money on their phones. You can invest today for just $0.26/share with a $1000 minimum.
Cuban has long been vocal about the failures of the U.S. healthcare system, particularly when it comes to drug pricing. His company sells medications with a flat 15% markup, eliminating the middlemen that drive up costs. Since launching in 2022, Cost Plus Drugs has expanded to over 2,500 medications and is already pushing major industry players to reconsider their pricing models.
Cuban has many times spoken out against pharmacy benefit managers, saying they have become too focused on making money. He believes they were originally supposed to help lower drug prices, but now they are just trying to control more of the industry and raise profits.
